5FJ-30814-86638
2 vaccinations
1 coded response
8 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 171 / PA
- Registered
- 2021-12-07
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-12-06
Dose 1 — Pfizer-BioNTech
-
2021-12-07
Registered in v-safe
-
2021-12-07
Survey response — days 1–6 daily, dose 1MedDRA: Muscle contractions involuntary — Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Be unable to do your normal daily activitiesFree text: Intense contractions in lower backMedDRA releases: 2024-11 · check-in free text available
- 2021-12-08
- 2021-12-09
- 2021-12-10
-
2021-12-27
Dose 2 — Pfizer-BioNTech
- 2021-12-27
-
2021-12-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-12-30
- 2022-01-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-12-06 | Pfizer-BioNTech | No |
| 2 | 2021-12-27 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 1
Systemic reaction (other): Intense contractions in lower back
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Muscle contractions involuntary | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release